Table 3 Clinical evaluation of patients and control (all from the same family)
| Â | Patient age at onset and gender | Main clinical manifestations | Cells source |
|---|---|---|---|
DCM-R (patient) | 16, male | Severe LV dilatation. Severe global LV dysfunction. Ventricular tachycardia | Primary human fibroblasts from skin punch |
DCM-O (patient) | 13, male | Severe LV dilatation. Severe global LV dysfunction | Primary human fibroblasts from pacemaker replacement procedure |
DCM-C (Control) | 12, male | Control from the same family | Primary human fibroblasts from skin punch |